Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review

PURPOSE OF THE REVIEW: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended for eligible patients with type 2 diabetes for the secondary prevention of adverse cardiovascular and kidney disease outcomes. Patients with type 2 diabetes and albuminuric chronic kidney disease, a history of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubrofsky, Lisa, Srivastava, Anand, Cherney, David Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315675/
https://www.ncbi.nlm.nih.gov/pubmed/32637144
http://dx.doi.org/10.1177/2054358120935701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315675/
https://www.ncbi.nlm.nih.gov/pubmed/32637144
http://dx.doi.org/10.1177/2054358120935701

Ejemplares similares